Results 21 to 30 of about 293,060 (357)

Factors Associated with Late Presentation of HIV and Estimation of Antiretroviral Treatment Need according to CD4 Lymphocyte Count in a Resource-Limited Setting: Data from an HIV Cohort Study in India [PDF]

open access: goldInterdisciplinary Perspectives on Infectious Diseases, 2012
We describe the CD4 lymphocyte count at HIV presentation in an HIV cohort from a rural district of India. The majority of patients were diagnosed for their HIV-related symptoms, although a sizeable proportion of women were diagnosed because of antenatal ...
Gerardo Alvarez‐Uria   +5 more
openalex   +2 more sources

Association of T lymphocytes level and clinical severity in patients of COVID-19 in Shenzhen China

open access: yesEuropean Journal of Inflammation, 2021
To explore the correlation between T lymphocytes and clinical severity in patients of COVID-19. A total of 183 COVID-19 patients were recruited in Shenzhen Third People’s Hospital from January 11 to February 16, 2020.
Wu Qiang   +6 more
doaj   +1 more source

Role of CD4+T, CD8+T Cells, and CD4+T/CD8+T Cell Ratio in Gastric Cancer and Its Clinical Significance

open access: yesApplied Bionics and Biomechanics, 2022
Objective. To study the expression and clinical importance of CD4+T, CD8+T cells, and CD4+T/CD8+T cell percentage in gastric cancer (GC) patients. Methods.
Jingqi Han   +6 more
doaj   +1 more source

The CD4+ T-lymphocyte count is an important predictor for the prognosis of cryptococcosis [PDF]

open access: yesEuropean Journal of Clinical Microbiology & Infectious Diseases, 2016
There is great heterogeneity of immunity among patients with cryptococcosis, and severe immunodeficiency can lead to negative clinical outcomes. Underlying disease is a poor surrogate for immune status and inferior in predicting an individual's prognosis.
Ming-Ming Tan   +8 more
openaire   +3 more sources

CD4+ T-Lymphocyte Count/CD8+ T-Lymphocyte Count Ratio: Surrogate for HIV Infection in Infants? [PDF]

open access: yesJournal of Tropical Pediatrics, 2012
Early diagnosis and treatment is necessary to prevent HIV-infected infants progressing to AIDS. Antibody testing is not confirmatory before the age of 18 months and PCR not widely available in resource-poor settings. We studied the accuracy of CD4(+) T-lymphocyte count, CD4% and CD4/CD8 ratio as surrogate markers of infant HIV infection.Two hundred and
Navaneethapandian, P. G. D.   +5 more
openaire   +4 more sources

Disease progression and its influencing factors among HIV/AIDS patients on antiretroviral therapy in Yili, Xinjiang Uygur Autonomous Region: a multi-state Markov model analysis on follow-up data

open access: yesZhongguo gonggong weisheng, 2023
ObjectiveTo analyze disease progression and its influencing factors in human immunodeficiency virus/acquired immune deficiency syndrome (HIV/AIDS) patients on antiretroviral therapy (ART) with Markov modeling.MethodsWe recruited a total of 2 000 HIV/AIDS
Arezu·Rouziniyazi   +5 more
doaj   +1 more source

Physics of a rapid CD4 lymphocyte count with colloidal gold [PDF]

open access: yesCytometry Part A, 2011
AbstractThe inherent surface charges and small diameters that confer colloidal stability to gold particle conjugates (immunogold) are detrimental to rapid cell surface labeling and distinct cluster definition in flow cytometric light scatter assays.
A. Restell   +6 more
openaire   +3 more sources

Emerging technologies for point-of-care CD4 T-lymphocyte counting [PDF]

open access: yesTrends in Biotechnology, 2012
A CD4 T-lymphocyte count determines eligibility for antiretroviral therapy (ART) in patients recently diagnosed with HIV and also monitors the efficacy of ART treatment thereafter. ART slows the progression of HIV to AIDS. In the developing world, CD4 tests are often performed in centralized laboratories, typically in urban areas.
Kenneth R. Hawkins   +4 more
openaire   +3 more sources

ELYPSE-7: a randomized placebo-controlled phase IIa trial with CYT107 exploring the restoration of CD4+ lymphocyte count in lymphopenic metastatic breast cancer patients.

open access: yesAnnals of Oncology, 2018
ELYPSE-7: a randomized placebo-controlled phase IIa trial with CYT107 exploring the restoration of CD4 lymphocyte count in lymphopenic metastatic breast cancer patients O. Trédan1,2,3,4,, C. Ménétrier-Caux2,3,4,5,6,, I. Ray-Coquard1,2,3,4,*, G. Garin7, C.
O. Trédan   +23 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy